Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AMG 910 |
Trade Name | |
Synonyms | AMG-910|AMG910|Bispecific Antibody AMG 910 |
Drug Descriptions |
AMG 910 is a bispecific T-cell engager (BiTE) that targets CLDN18.2 expressed on tumor cells, and the CD3 antigen found on cytotoxic T cell lymphocytes, potentially resulting in T cell directed lysis of tumor cells (Ann Oncol. 2020 Sep 1;31(Supple. 4):S928-S929). |
DrugClasses | CLDN18.2 Antibody 19 |
CAS Registry Number | NA |
NCIT ID | C170815 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AMG 910 | AMG 910 | 0 | 1 |